| Tyler Kloven, DO | |
|
750 Ne 13th St, Oklahoma City, OK 73104-5010 | |
| (405) 271-4351 | |
| Not Available |
| Full Name | Tyler Kloven |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 11 Years |
| Location | 750 Ne 13th St, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205272713 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | R0742 (Texas) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baylor Scott & White All Saints Medical Center Fort Worth | Fort worth, TX | Hospital |
| Baylor Scott & White Heart & Vascular Hospital - Dallas | Dallas, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northstar Anesthesia Iii Pa | 0042630501 | 335 |
| Northstar Anesthesia Pa | 7315907128 | 290 |
News Archive
Pfizer Inc. today announced that the U.S. Food and Drug Administration approved MYLOTARG (gemtuzumab ozogamicin) for adults with newly diagnosed CD33-positive acute myeloid leukemia (AML), and adults and children 2 years and older with relapsed or refractory CD33-positive AML.
Using a new MRI technique, researchers found that adults with mild cognitive impairment (MCI) who exercised four times a week over a six-month period experienced an increase in brain volume in specific, or local, areas of the brain, but adults who participated in aerobic exercise experienced greater gains than those who just stretched.
Physicians at the Methodist DeBakey Heart & Vascular Center in Houston implanted a new investigational heart valve in a patient through a small puncture hole in the leg.
The question of whether or not to continue to pursue the development of T-cell-based HIV-1 vaccines has been a source of controversy following last year's widely publicized failure of the field's most promising candidate, a vaccine developed by Merck known as V520.
Research from the University of Alberta's Faculty of Medicine & Dentistry is revealing the heavy surgical consequences of severe obesity.
› Verified 5 days ago
| Entity Name | U S Anesthesia Partners Of Texas, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548208564 PECOS PAC ID: 7315850351 Enrollment ID: O20031106000563 |
News Archive
Pfizer Inc. today announced that the U.S. Food and Drug Administration approved MYLOTARG (gemtuzumab ozogamicin) for adults with newly diagnosed CD33-positive acute myeloid leukemia (AML), and adults and children 2 years and older with relapsed or refractory CD33-positive AML.
Using a new MRI technique, researchers found that adults with mild cognitive impairment (MCI) who exercised four times a week over a six-month period experienced an increase in brain volume in specific, or local, areas of the brain, but adults who participated in aerobic exercise experienced greater gains than those who just stretched.
Physicians at the Methodist DeBakey Heart & Vascular Center in Houston implanted a new investigational heart valve in a patient through a small puncture hole in the leg.
The question of whether or not to continue to pursue the development of T-cell-based HIV-1 vaccines has been a source of controversy following last year's widely publicized failure of the field's most promising candidate, a vaccine developed by Merck known as V520.
Research from the University of Alberta's Faculty of Medicine & Dentistry is revealing the heavy surgical consequences of severe obesity.
› Verified 5 days ago
| Entity Name | Northstar Anesthesia Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912978610 PECOS PAC ID: 7315907128 Enrollment ID: O20041015000685 |
News Archive
Pfizer Inc. today announced that the U.S. Food and Drug Administration approved MYLOTARG (gemtuzumab ozogamicin) for adults with newly diagnosed CD33-positive acute myeloid leukemia (AML), and adults and children 2 years and older with relapsed or refractory CD33-positive AML.
Using a new MRI technique, researchers found that adults with mild cognitive impairment (MCI) who exercised four times a week over a six-month period experienced an increase in brain volume in specific, or local, areas of the brain, but adults who participated in aerobic exercise experienced greater gains than those who just stretched.
Physicians at the Methodist DeBakey Heart & Vascular Center in Houston implanted a new investigational heart valve in a patient through a small puncture hole in the leg.
The question of whether or not to continue to pursue the development of T-cell-based HIV-1 vaccines has been a source of controversy following last year's widely publicized failure of the field's most promising candidate, a vaccine developed by Merck known as V520.
Research from the University of Alberta's Faculty of Medicine & Dentistry is revealing the heavy surgical consequences of severe obesity.
› Verified 5 days ago
| Entity Name | Northstar Anesthesia Ii Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477066405 PECOS PAC ID: 2365701737 Enrollment ID: O20180110000102 |
News Archive
Pfizer Inc. today announced that the U.S. Food and Drug Administration approved MYLOTARG (gemtuzumab ozogamicin) for adults with newly diagnosed CD33-positive acute myeloid leukemia (AML), and adults and children 2 years and older with relapsed or refractory CD33-positive AML.
Using a new MRI technique, researchers found that adults with mild cognitive impairment (MCI) who exercised four times a week over a six-month period experienced an increase in brain volume in specific, or local, areas of the brain, but adults who participated in aerobic exercise experienced greater gains than those who just stretched.
Physicians at the Methodist DeBakey Heart & Vascular Center in Houston implanted a new investigational heart valve in a patient through a small puncture hole in the leg.
The question of whether or not to continue to pursue the development of T-cell-based HIV-1 vaccines has been a source of controversy following last year's widely publicized failure of the field's most promising candidate, a vaccine developed by Merck known as V520.
Research from the University of Alberta's Faculty of Medicine & Dentistry is revealing the heavy surgical consequences of severe obesity.
› Verified 5 days ago
| Entity Name | Northstar Anesthesia Iii Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356968952 PECOS PAC ID: 0042630501 Enrollment ID: O20201022000080 |
News Archive
Pfizer Inc. today announced that the U.S. Food and Drug Administration approved MYLOTARG (gemtuzumab ozogamicin) for adults with newly diagnosed CD33-positive acute myeloid leukemia (AML), and adults and children 2 years and older with relapsed or refractory CD33-positive AML.
Using a new MRI technique, researchers found that adults with mild cognitive impairment (MCI) who exercised four times a week over a six-month period experienced an increase in brain volume in specific, or local, areas of the brain, but adults who participated in aerobic exercise experienced greater gains than those who just stretched.
Physicians at the Methodist DeBakey Heart & Vascular Center in Houston implanted a new investigational heart valve in a patient through a small puncture hole in the leg.
The question of whether or not to continue to pursue the development of T-cell-based HIV-1 vaccines has been a source of controversy following last year's widely publicized failure of the field's most promising candidate, a vaccine developed by Merck known as V520.
Research from the University of Alberta's Faculty of Medicine & Dentistry is revealing the heavy surgical consequences of severe obesity.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tyler Kloven, DO 750 Ne 13th St, Oklahoma City, OK 73104-5010 Ph: (405) 271-4351 | Tyler Kloven, DO 750 Ne 13th St, Oklahoma City, OK 73104-5010 Ph: (405) 271-4351 |
News Archive
Pfizer Inc. today announced that the U.S. Food and Drug Administration approved MYLOTARG (gemtuzumab ozogamicin) for adults with newly diagnosed CD33-positive acute myeloid leukemia (AML), and adults and children 2 years and older with relapsed or refractory CD33-positive AML.
Using a new MRI technique, researchers found that adults with mild cognitive impairment (MCI) who exercised four times a week over a six-month period experienced an increase in brain volume in specific, or local, areas of the brain, but adults who participated in aerobic exercise experienced greater gains than those who just stretched.
Physicians at the Methodist DeBakey Heart & Vascular Center in Houston implanted a new investigational heart valve in a patient through a small puncture hole in the leg.
The question of whether or not to continue to pursue the development of T-cell-based HIV-1 vaccines has been a source of controversy following last year's widely publicized failure of the field's most promising candidate, a vaccine developed by Merck known as V520.
Research from the University of Alberta's Faculty of Medicine & Dentistry is revealing the heavy surgical consequences of severe obesity.
› Verified 5 days ago
Dr. Elizabeth Anne Williams, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 6201 Beaver Creek Rd, Oklahoma City, OK 73162 Phone: 405-210-4198 Fax: 405-703-7595 | |
Dr. Steven J Lantier, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 9500 Broadway Ext, Oklahoma City, OK 73114 Phone: 405-475-0680 | |
Dr. Martin J Lopez, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4525 S Klein Ave, Ste 900, Oklahoma City, OK 73109 Phone: 405-636-1797 | |
Betty J Haywood, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 750 Ne 13th St, Oac 200, Oklahoma City, OK 73104 Phone: 405-271-4351 Fax: 405-271-8695 | |
Dr. Suhal S Mahid, MD, PHD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1000 N Lee Ave, Oklahoma City, OK 73102 Phone: 405-272-8000 | |
Dr. Lauren L. Fitzgerald, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 4401 S Western Ave, Oklahoma City, OK 73109 Phone: 918-392-2944 Fax: 918-664-2521 | |
Sathish Ramanathan, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 920 Stanton L Young Blvd # Wp1140, Oklahoma City, OK 73104 Phone: 405-271-4351 Fax: 405-271-8695 |